The U.S. Department of Justice announced on Friday that Pfizer Inc.
Get Free Report
, on behalf of its subsidiary Biohaven Ltd.
+ Free Alerts
(Biohaven), agreed to pay $59,746,277 to resolve allegations that Biohaven knowingly caused the submission of false claims to Medicare by paying kickbacks to health care providers to induce prescriptions of its drug Nurtec ODT.
The DOJ alleges that from March 1, 2020, through Sept. 30, 2022, Biohaven paid health care professionals, in the form of paid speaking appearances and expensive meals, to induce them to prescribe the medication which violates the anti-kickback statute.
Read Next: Rigetti Computing, Quantum Stocks Soar On Project Stargate
"Patients deserve to know that their doctor is prescribing medications based on their doctor's medical judgment, and not as a result of financial incentives from pharmaceutical companies," said U.S. Attorney Trini E. Ross for the Western District of New York.
"This settlement reflects our commitment to hold those who violate the laws accountable, regardless of their status or prestige," Ross added.
Last Tuesday, the Securities and Exchange Commission announced the creation of a crypto task force, led by Commissioner Hester Peirce and dedicated to the development of a clear and comprehensive regulatory framework for crypto assets.
The SEC said the current legal confusion...
The US Department of Justice announced Friday that Pfizer (NYSE: PFE) has agreed in the New York federal court to pay $59.7 million to resolve allegations that one of its subsidiaries caused false...